Neutralizing antibodies against adeno-associated viruses in Sjögren’s patients: implications for gene therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-04

AUTHORS

A Corden, B Handelman, H Yin, A Cotrim, I Alevizos, J A Chiorini

ABSTRACT

One potential setback to the use of gene therapy for the treatment of Sjögren's syndrome is the presence of neutralizing antibodies (nAb) against adeno-associated virus (AAV) serotypes. In order to evaluate the efficacy of this treatment option, nAb titers were measured in both healthy individuals and Sjögren's patients. Several serotypes with known transduction activity in mouse salivary glands were tested and only AAV5 showed a statistically significant change in the prevalence of nAbs between Sjögren's and healthy participants. Both groups showed a higher rate of nAbs for AAV2 compared with most of the other serotypes tested, except for bovine AAV (BAAV). Although a similar rate of seropositivity was seen against BAAV and AAV2, the percentage of samples with high titer was significantly lower with BAAV. Furthermore, the majority of positive samples exhibited low nAb titers in the primary Sjögren's syndrome (pSS) group for all serotypes except for AAV2. AAV5 was the only serotype that showed a statistically significant shift in the percentage of medium or high neutralizing titer. Based on these results, many serotypes are viable vectors in a gene therapy approach and pSS patients do not have a statistically significant higher rate of seropositivity or titer compared with healthy donors. More... »

PAGES

241

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/gt.2017.1

DOI

http://dx.doi.org/10.1038/gt.2017.1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083404611

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28150697


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1004", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Neutralizing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cattle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dependovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Vectors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salivary Glands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sjogren's Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transduction, Genetic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Corden", 
        "givenName": "A", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Handelman", 
        "givenName": "B", 
        "id": "sg:person.0647535754.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647535754.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yin", 
        "givenName": "H", 
        "id": "sg:person.01204622042.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204622042.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cotrim", 
        "givenName": "A", 
        "id": "sg:person.01323424713.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323424713.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alevizos", 
        "givenName": "I", 
        "id": "sg:person.01346655332.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655332.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institute of Dental and Craniofacial Research", 
          "id": "https://www.grid.ac/institutes/grid.419633.a", 
          "name": [
            "Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiorini", 
        "givenName": "J A", 
        "id": "sg:person.013076324754.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013076324754.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1128/jvi.75.13.6199-6203.2001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001359000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.virol.2006.11.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002293476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0510837103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002584663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-10-3296", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003619350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/595830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005676087"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1601-0825.2011.01885.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006460615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008392976"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/labinvest.2010.164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009934766", 
          "https://doi.org/10.1038/labinvest.2010.164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012134968", 
          "https://doi.org/10.1038/nm1358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012134968", 
          "https://doi.org/10.1038/nm1358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri891", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018512919", 
          "https://doi.org/10.1038/nri891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri891", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018512919", 
          "https://doi.org/10.1038/nri891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jgm.678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019063185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000172801.56744.c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020913045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000172801.56744.c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020913045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000172801.56744.c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020913045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-010-0837-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023662376", 
          "https://doi.org/10.1007/s00520-010-0837-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-010-0837-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023662376", 
          "https://doi.org/10.1007/s00520-010-0837-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.02012-07", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023680307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3302691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027239070", 
          "https://doi.org/10.1038/sj.gt.3302691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.gt.3302691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027239070", 
          "https://doi.org/10.1038/sj.gt.3302691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.21673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031175644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.21673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031175644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-7-46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032971037", 
          "https://doi.org/10.1186/1477-7525-7-46"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)66990-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033282870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)66990-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033282870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1210662109", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035209129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.78.12.6509-6516.2004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046706944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2005.038232", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047233762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/joe.1.06171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050892461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar3753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050935954", 
          "https://doi.org/10.1186/ar3753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052024460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/hum.2006.17.440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059272782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2144/02331dd04", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075092722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075124865", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-04", 
    "datePublishedReg": "2017-04-01", 
    "description": "One potential setback to the use of gene therapy for the treatment of Sj\u00f6gren's syndrome is the presence of neutralizing antibodies (nAb) against adeno-associated virus (AAV) serotypes. In order to evaluate the efficacy of this treatment option, nAb titers were measured in both healthy individuals and Sj\u00f6gren's patients. Several serotypes with known transduction activity in mouse salivary glands were tested and only AAV5 showed a statistically significant change in the prevalence of nAbs between Sj\u00f6gren's and healthy participants. Both groups showed a higher rate of nAbs for AAV2 compared with most of the other serotypes tested, except for bovine AAV (BAAV). Although a similar rate of seropositivity was seen against BAAV and AAV2, the percentage of samples with high titer was significantly lower with BAAV. Furthermore, the majority of positive samples exhibited low nAb titers in the primary Sj\u00f6gren's syndrome (pSS) group for all serotypes except for AAV2. AAV5 was the only serotype that showed a statistically significant shift in the percentage of medium or high neutralizing titer. Based on these results, many serotypes are viable vectors in a gene therapy approach and pSS patients do not have a statistically significant higher rate of seropositivity or titer compared with healthy donors.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/gt.2017.1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2724672", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2724652", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2724656", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2715904", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "name": "Neutralizing antibodies against adeno-associated viruses in Sj\u00f6gren\u2019s patients: implications for gene therapy", 
    "pagination": "241", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a36860b8babdf2e811c25228ab314e4d5b6146de11022be37d0e66e0161f566a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28150697"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9421525"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/gt.2017.1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083404611"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/gt.2017.1", 
      "https://app.dimensions.ai/details/publication/pub.1083404611"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000427.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/gt20171"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/gt.2017.1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/gt.2017.1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/gt.2017.1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/gt.2017.1'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      74 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/gt.2017.1 schema:about N07879cad9a5f4cc7860dc054ca35301a
2 N0debd0a45aa3420092dc05752a8a4c3a
3 N0e245caf3d474357a1484bddfc62a468
4 N1a832d5a8c334f43919ec9f332c91720
5 N1fb808bbadfa45acac813ff6a12c3a5e
6 N2d208c527d274968acf4bfac42cb95eb
7 N449110b882564d6786937c34e85992bf
8 N4c9fd7e8db864408b9e3a14e60cde1f3
9 N54fb2cef7a0e46a5abca840b921559c4
10 N55c0b205f23947e2aa2c230382db8aae
11 N637e062b35004b80b388c0214ac3a8a5
12 N7def5b0ed95e4fd7a7a88e1a7a95b31f
13 N8d0e7937e6fd445b8cf51db6a40d94f1
14 Nae11119f1b3d49e3aba1ab217a52783c
15 Nb5d38a5078334e3090f36d828d7002af
16 Nd47e74f9b7bd4381be3d7179cad57dff
17 Ndb8ae03d977b4443862915a627bf76a2
18 Ne2a6dacb0fbb46feb69d2a1b4ccb73af
19 anzsrc-for:10
20 anzsrc-for:1004
21 schema:author N87f57e560a82402387810bd1d3a1b3cb
22 schema:citation sg:pub.10.1007/s00520-010-0837-6
23 sg:pub.10.1038/labinvest.2010.164
24 sg:pub.10.1038/nm1358
25 sg:pub.10.1038/nri891
26 sg:pub.10.1038/sj.gt.3302691
27 sg:pub.10.1186/1477-7525-7-46
28 sg:pub.10.1186/ar3753
29 https://app.dimensions.ai/details/publication/pub.1075124865
30 https://doi.org/10.1002/art.10674
31 https://doi.org/10.1002/art.20146
32 https://doi.org/10.1002/ibd.21673
33 https://doi.org/10.1002/jgm.678
34 https://doi.org/10.1016/j.virol.2006.11.032
35 https://doi.org/10.1016/s0140-6736(05)66990-5
36 https://doi.org/10.1073/pnas.0510837103
37 https://doi.org/10.1073/pnas.1210662109
38 https://doi.org/10.1086/595830
39 https://doi.org/10.1089/hum.2006.17.440
40 https://doi.org/10.1097/01.bor.0000172801.56744.c3
41 https://doi.org/10.1111/j.1601-0825.2011.01885.x
42 https://doi.org/10.1128/jvi.02012-07
43 https://doi.org/10.1128/jvi.75.13.6199-6203.2001
44 https://doi.org/10.1128/jvi.78.12.6509-6516.2004
45 https://doi.org/10.1136/ard.2005.038232
46 https://doi.org/10.1182/blood-2002-10-3296
47 https://doi.org/10.1677/joe.1.06171
48 https://doi.org/10.2144/02331dd04
49 schema:datePublished 2017-04
50 schema:datePublishedReg 2017-04-01
51 schema:description One potential setback to the use of gene therapy for the treatment of Sjögren's syndrome is the presence of neutralizing antibodies (nAb) against adeno-associated virus (AAV) serotypes. In order to evaluate the efficacy of this treatment option, nAb titers were measured in both healthy individuals and Sjögren's patients. Several serotypes with known transduction activity in mouse salivary glands were tested and only AAV5 showed a statistically significant change in the prevalence of nAbs between Sjögren's and healthy participants. Both groups showed a higher rate of nAbs for AAV2 compared with most of the other serotypes tested, except for bovine AAV (BAAV). Although a similar rate of seropositivity was seen against BAAV and AAV2, the percentage of samples with high titer was significantly lower with BAAV. Furthermore, the majority of positive samples exhibited low nAb titers in the primary Sjögren's syndrome (pSS) group for all serotypes except for AAV2. AAV5 was the only serotype that showed a statistically significant shift in the percentage of medium or high neutralizing titer. Based on these results, many serotypes are viable vectors in a gene therapy approach and pSS patients do not have a statistically significant higher rate of seropositivity or titer compared with healthy donors.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf Nbed77b6e594448769915b3d707ef5358
56 Ne94229901fc34847a4479cff5588b7db
57 sg:journal.1105638
58 schema:name Neutralizing antibodies against adeno-associated viruses in Sjögren’s patients: implications for gene therapy
59 schema:pagination 241
60 schema:productId N21ec3303a8da4a918dcf5fe5b26a89ca
61 N2708e9818fa74b5192c77ed47d5a2147
62 N33ef0082077646e5a6781afe1776c6f5
63 N514f150762644921a6d82fa4f59764eb
64 N79bb9597f99b4fd8becf88badd322914
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083404611
66 https://doi.org/10.1038/gt.2017.1
67 schema:sdDatePublished 2019-04-10T21:25
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nb43cb7751b734bc59c14657f0b95fba5
70 schema:url https://www.nature.com/articles/gt20171
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N07879cad9a5f4cc7860dc054ca35301a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Genetic Vectors
76 rdf:type schema:DefinedTerm
77 N0a46c2e7a11148b6b6fb1d3766b4a752 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
78 schema:familyName Corden
79 schema:givenName A
80 rdf:type schema:Person
81 N0debd0a45aa3420092dc05752a8a4c3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Aged
83 rdf:type schema:DefinedTerm
84 N0e245caf3d474357a1484bddfc62a468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Animals
86 rdf:type schema:DefinedTerm
87 N1a832d5a8c334f43919ec9f332c91720 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Adolescent
89 rdf:type schema:DefinedTerm
90 N1fb808bbadfa45acac813ff6a12c3a5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Humans
92 rdf:type schema:DefinedTerm
93 N21ec3303a8da4a918dcf5fe5b26a89ca schema:name pubmed_id
94 schema:value 28150697
95 rdf:type schema:PropertyValue
96 N2708e9818fa74b5192c77ed47d5a2147 schema:name doi
97 schema:value 10.1038/gt.2017.1
98 rdf:type schema:PropertyValue
99 N2c9cdc4ba10a461dbf92660e829c7ef6 rdf:first sg:person.01323424713.08
100 rdf:rest Nf3da47e871194cd7976424f33b8fe0f9
101 N2d208c527d274968acf4bfac42cb95eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Antibodies, Viral
103 rdf:type schema:DefinedTerm
104 N33ef0082077646e5a6781afe1776c6f5 schema:name dimensions_id
105 schema:value pub.1083404611
106 rdf:type schema:PropertyValue
107 N449110b882564d6786937c34e85992bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Sjogren's Syndrome
109 rdf:type schema:DefinedTerm
110 N4a08cbf9a8874de8ada33f10f7b8f171 rdf:first sg:person.01204622042.23
111 rdf:rest N2c9cdc4ba10a461dbf92660e829c7ef6
112 N4c9fd7e8db864408b9e3a14e60cde1f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Transduction, Genetic
114 rdf:type schema:DefinedTerm
115 N514f150762644921a6d82fa4f59764eb schema:name nlm_unique_id
116 schema:value 9421525
117 rdf:type schema:PropertyValue
118 N54fb2cef7a0e46a5abca840b921559c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 N55c0b205f23947e2aa2c230382db8aae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N637e062b35004b80b388c0214ac3a8a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Female
126 rdf:type schema:DefinedTerm
127 N79bb9597f99b4fd8becf88badd322914 schema:name readcube_id
128 schema:value a36860b8babdf2e811c25228ab314e4d5b6146de11022be37d0e66e0161f566a
129 rdf:type schema:PropertyValue
130 N7def5b0ed95e4fd7a7a88e1a7a95b31f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Mice
132 rdf:type schema:DefinedTerm
133 N87f57e560a82402387810bd1d3a1b3cb rdf:first N0a46c2e7a11148b6b6fb1d3766b4a752
134 rdf:rest N99cd4c0775e34fa19901ff24aadadcee
135 N8d0e7937e6fd445b8cf51db6a40d94f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Dependovirus
137 rdf:type schema:DefinedTerm
138 N99cd4c0775e34fa19901ff24aadadcee rdf:first sg:person.0647535754.51
139 rdf:rest N4a08cbf9a8874de8ada33f10f7b8f171
140 Nae11119f1b3d49e3aba1ab217a52783c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antibodies, Neutralizing
142 rdf:type schema:DefinedTerm
143 Nb43cb7751b734bc59c14657f0b95fba5 schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 Nb5d38a5078334e3090f36d828d7002af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Cattle
147 rdf:type schema:DefinedTerm
148 Nbed77b6e594448769915b3d707ef5358 schema:issueNumber 4
149 rdf:type schema:PublicationIssue
150 Nd47e74f9b7bd4381be3d7179cad57dff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Genetic Therapy
152 rdf:type schema:DefinedTerm
153 Ndb8ae03d977b4443862915a627bf76a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Adult
155 rdf:type schema:DefinedTerm
156 Ne2a6dacb0fbb46feb69d2a1b4ccb73af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Salivary Glands
158 rdf:type schema:DefinedTerm
159 Ne94229901fc34847a4479cff5588b7db schema:volumeNumber 24
160 rdf:type schema:PublicationVolume
161 Nf3da47e871194cd7976424f33b8fe0f9 rdf:first sg:person.01346655332.16
162 rdf:rest Nfda65668339644b6abd596d4ec964410
163 Nfda65668339644b6abd596d4ec964410 rdf:first sg:person.013076324754.21
164 rdf:rest rdf:nil
165 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
166 schema:name Technology
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1004 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical Biotechnology
170 rdf:type schema:DefinedTerm
171 sg:grant.2715904 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2017.1
172 rdf:type schema:MonetaryGrant
173 sg:grant.2724652 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2017.1
174 rdf:type schema:MonetaryGrant
175 sg:grant.2724656 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2017.1
176 rdf:type schema:MonetaryGrant
177 sg:grant.2724672 http://pending.schema.org/fundedItem sg:pub.10.1038/gt.2017.1
178 rdf:type schema:MonetaryGrant
179 sg:journal.1105638 schema:issn 0969-7128
180 1476-5462
181 schema:name Gene Therapy
182 rdf:type schema:Periodical
183 sg:person.01204622042.23 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
184 schema:familyName Yin
185 schema:givenName H
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204622042.23
187 rdf:type schema:Person
188 sg:person.013076324754.21 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
189 schema:familyName Chiorini
190 schema:givenName J A
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013076324754.21
192 rdf:type schema:Person
193 sg:person.01323424713.08 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
194 schema:familyName Cotrim
195 schema:givenName A
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323424713.08
197 rdf:type schema:Person
198 sg:person.01346655332.16 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
199 schema:familyName Alevizos
200 schema:givenName I
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655332.16
202 rdf:type schema:Person
203 sg:person.0647535754.51 schema:affiliation https://www.grid.ac/institutes/grid.419633.a
204 schema:familyName Handelman
205 schema:givenName B
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647535754.51
207 rdf:type schema:Person
208 sg:pub.10.1007/s00520-010-0837-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023662376
209 https://doi.org/10.1007/s00520-010-0837-6
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/labinvest.2010.164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009934766
212 https://doi.org/10.1038/labinvest.2010.164
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/nm1358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012134968
215 https://doi.org/10.1038/nm1358
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/nri891 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018512919
218 https://doi.org/10.1038/nri891
219 rdf:type schema:CreativeWork
220 sg:pub.10.1038/sj.gt.3302691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027239070
221 https://doi.org/10.1038/sj.gt.3302691
222 rdf:type schema:CreativeWork
223 sg:pub.10.1186/1477-7525-7-46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032971037
224 https://doi.org/10.1186/1477-7525-7-46
225 rdf:type schema:CreativeWork
226 sg:pub.10.1186/ar3753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050935954
227 https://doi.org/10.1186/ar3753
228 rdf:type schema:CreativeWork
229 https://app.dimensions.ai/details/publication/pub.1075124865 schema:CreativeWork
230 https://doi.org/10.1002/art.10674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052024460
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1002/art.20146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008392976
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1002/ibd.21673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031175644
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1002/jgm.678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019063185
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.virol.2006.11.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002293476
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0140-6736(05)66990-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033282870
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1073/pnas.0510837103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002584663
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1073/pnas.1210662109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035209129
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1086/595830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005676087
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1089/hum.2006.17.440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059272782
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1097/01.bor.0000172801.56744.c3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020913045
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1111/j.1601-0825.2011.01885.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006460615
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1128/jvi.02012-07 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023680307
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1128/jvi.75.13.6199-6203.2001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001359000
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1128/jvi.78.12.6509-6516.2004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046706944
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1136/ard.2005.038232 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047233762
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1182/blood-2002-10-3296 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003619350
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1677/joe.1.06171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050892461
265 rdf:type schema:CreativeWork
266 https://doi.org/10.2144/02331dd04 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075092722
267 rdf:type schema:CreativeWork
268 https://www.grid.ac/institutes/grid.419633.a schema:alternateName National Institute of Dental and Craniofacial Research
269 schema:name Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...